| Dr Benjamin Dwight Renelus, MD | |
|
8901 Stonebridge Blvd Fl 2, Douglasville, GA 30134-2244 | |
| (943) 202-7120 | |
| Not Available |
| Full Name | Dr Benjamin Dwight Renelus |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 8901 Stonebridge Blvd Fl 2, Douglasville, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760827331 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | D0092002 (Maryland) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 76667 (Georgia) | Primary |
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
BioMarin Pharmaceutical Inc. announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for the treatment of Pompe disease. An investigational new drug application (IND) for BMN-701 has been submitted, investigational material has been manufactured and a Phase I/II study is expected to start in the first quarter of 2011.
Amblyopia, known as "lazy eye," is a major cause of vision problems in children and a common cause of blindness in people aged 20 to 70 in developed countries. In amblyopia the person's stronger eye is favored and his/her weaker eye gradually loses visual power as a result. When the condition is detected and treated before age 7, more than 75 percent of children achieve 20/30 vision or better, the Amblyopia Treatment Study reports.
Beginning today, thousands of people who want to help put an end to diabetes can be part of the cure by participating in the Diabetes Research Institute Foundation's online campaign at BePartoftheCure.org. Kicking off National Diabetes Awareness Month, the Be Part of the CURE campaign is a fun and meaningful way for people living with diabetes, their family and friends, and anyone concerned about curing this devastating disease to literally participate in the "CURE."
Colorectal cancer rates among young adults are steadily increasing over the years. The United States Task Force has long recommended that people aged 50 to 75 get screened. Now, the U.S. Preventive Services Task Force updated its 2016 recommendation of colorectal screening for people aged 50, down to 45 years old. The five-year earlier screening can save many lives by allowing earlier diagnosis and treatment of the condition.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin Dwight Renelus, MD 8901 Stonebridge Blvd Fl 2, Douglasville, GA 30134-2244 Ph: (943) 202-7120 | Dr Benjamin Dwight Renelus, MD 8901 Stonebridge Blvd Fl 2, Douglasville, GA 30134-2244 Ph: (943) 202-7120 |
News Archive
BioMarin Pharmaceutical Inc. announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for the treatment of Pompe disease. An investigational new drug application (IND) for BMN-701 has been submitted, investigational material has been manufactured and a Phase I/II study is expected to start in the first quarter of 2011.
Amblyopia, known as "lazy eye," is a major cause of vision problems in children and a common cause of blindness in people aged 20 to 70 in developed countries. In amblyopia the person's stronger eye is favored and his/her weaker eye gradually loses visual power as a result. When the condition is detected and treated before age 7, more than 75 percent of children achieve 20/30 vision or better, the Amblyopia Treatment Study reports.
Beginning today, thousands of people who want to help put an end to diabetes can be part of the cure by participating in the Diabetes Research Institute Foundation's online campaign at BePartoftheCure.org. Kicking off National Diabetes Awareness Month, the Be Part of the CURE campaign is a fun and meaningful way for people living with diabetes, their family and friends, and anyone concerned about curing this devastating disease to literally participate in the "CURE."
Colorectal cancer rates among young adults are steadily increasing over the years. The United States Task Force has long recommended that people aged 50 to 75 get screened. Now, the U.S. Preventive Services Task Force updated its 2016 recommendation of colorectal screening for people aged 50, down to 45 years old. The five-year earlier screening can save many lives by allowing earlier diagnosis and treatment of the condition.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry.
› Verified 2 days ago
Safal Shetty, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6001 Professional Pkwy Ste 2020, Douglasville, GA 30134 Phone: 770-422-1372 | |
Michael B Piansky, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6043 Prestley Mill Rd Ste B, Douglasville, GA 30134 Phone: 770-941-8100 Fax: 678-945-9331 | |
Navinchandra M Ruparelia, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 4904 Timber Ridge Dr, Suite 202a, Douglasville, GA 30135 Phone: 770-949-6548 Fax: 770-949-9561 | |
Dr. Gray Akoegbe, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6001 Professional Pkwy Ste 2080, Douglasville, GA 30134 Phone: 678-715-5080 | |
Neal K Osborn, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8855 Hospital Dr, Suite 101, Douglasville, GA 30134 Phone: 678-784-5020 Fax: 678-784-5024 | |
Dr. Kathryn Amanda Mcfarland, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8687 Hospital Dr Ste 102, Douglasville, GA 30134 Phone: 678-785-5001 Fax: 888-464-0963 | |
Dr. Nana Abena Arthur, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8954 Hosptial Drive, Wellstar Health System Douglas Hospital, Douglasville, GA 30134 Phone: 678-838-2585 |